Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease

被引:72
作者
Ban, Y
Davies, TF
Greenberg, DA
Kissin, A
Marder, B
Murphy, B
Concepcion, ES
Villanueva, RB
Barbesino, G
Ling, V
Tomer, Y
机构
[1] CUNY Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA
[2] Columbia Univ, Div Stat Genet, New York, NY 10027 USA
[3] CUNY Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA
[4] Wyeth Ayerst Res, Dept Inflammat Biol, Biotechnol Grp, Cambridge, MA USA
关键词
autoimmune thyroid disease; genetics; susceptibility; function;
D O I
10.1038/sj.gene.6364018
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene on 2q33 is associated with autoimmune thyroid diseases (AITDs). Our earlier study in 56 families showed linkage of 2q33 to the presence of thyroid antibodies (TAbs). The goals of this study were to confirm the linkage of the 2q33 region to TAbs, to fine map this region, and study the ICOS gene. We performed a linkage study in an expanded data set of 99 multiplex AITD-TAb families ( 529 individuals). The highest two-point LOD score of 2.9 was obtained for marker D2S325 on 2q33. To fine map this locus, we genotyped 238 Caucasian AITD patients and 137 controls for five additional markers in the linked locus, which contained the CTLA-4, CD28, and ICOS genes. The A/G single-nucleotide polymorphism at position 49 of CTLA-4 was associated with AITD (P = 0.01, OR = 1.5), while markers inside CD28 and ICOS were not. Functional studies have shown that the G allele was associated with reduced inhibition of T-cell proliferation by CTLA-4. We concluded that: (1) the AITD gene in the 2q33 locus is the CTLA-4 gene and not the CD28 or ICOS genes; and (2) the G allele is associated with decreased function of CTLA-4.
引用
收藏
页码:586 / 593
页数:8
相关论文
共 53 条
[1]  
AHO K, 1983, ACTA ENDOCRINOL-COP, V102, P11
[2]   Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients [J].
Akamizu, T ;
Sale, MM ;
Rich, SS ;
Hiratani, H ;
Noh, JY ;
Kanamoto, N ;
Saijo, M ;
Miyamoto, Y ;
Saito, Y ;
Nakao, K ;
Bowden, DW .
THYROID, 2000, 10 (10) :851-858
[3]   MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease [J].
Allahabadia, A ;
Heward, JM ;
Nithiyananthan, R ;
Gibson, SM ;
Reuser, TTQ ;
Dodson, PM ;
Franklyn, JA ;
Gough, SCL .
LANCET, 2001, 358 (9286) :984-985
[4]  
[Anonymous], 1996, HUM MOL GENET
[5]   CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis [J].
Braun, J ;
Donner, H ;
Siegmund, T ;
Walfish, PG ;
Usadel, KH ;
Badenhoop, K .
TISSUE ANTIGENS, 1998, 51 (05) :563-566
[6]   What is the evidence of genetic factors in the etiology of Graves' disease? A brief review [J].
Brix, TH ;
Kyvik, KO ;
Hegedus, L .
THYROID, 1998, 8 (07) :627-634
[7]   A population-based study of chronic autoimmune hypothyroidism in Danish twins [J].
Brix, TH ;
Kyvik, KO ;
Hegedüs, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :536-539
[8]   THE PRESENCE OF THYROID AUTOANTIBODIES IN CHILDREN AND ADOLESCENTS WITH AUTOIMMUNE THYROID-DISEASE AND IN THEIR SIBLINGS AND PARENTS [J].
BUREK, CL ;
HOFFMAN, WH ;
ROSE, NR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 25 (03) :395-404
[9]   The CD28-related molecule ICOS is required for effective T cell-dependent immune responses [J].
Coyle, AJ ;
Lehar, S ;
Lloyd, C ;
Tian, J ;
Delaney, T ;
Manning, S ;
Nguyen, T ;
Burwell, T ;
Schneider, H ;
Gonzalo, JA ;
Gosselin, M ;
Owen, LR ;
Rudd, CE ;
Gutierrez-Ramos, JC .
IMMUNITY, 2000, 13 (01) :95-105
[10]   A comprehensive genetic map of the human genome based on 5,264 microsatellites [J].
Dib, C ;
Faure, S ;
Fizames, C ;
Samson, D ;
Drouot, N ;
Vignal, A ;
Millasseau, P ;
Marc, S ;
Hazan, J ;
Seboun, E ;
Lathrop, M ;
Gyapay, G ;
Morissette, J ;
Weissenbach, J .
NATURE, 1996, 380 (6570) :152-154